117 related articles for article (PubMed ID: 38518636)
1. Gualou-Xiebai herb pair and its active ingredients act against atherosclerosis by suppressing VSMC-derived foam cell formation via regulating P2RY12-mediated lipophagy.
Bao Y; Zhu L; Wang Y; Liu J; Liu Z; Li Z; Zhou A; Wu H
Phytomedicine; 2024 Jun; 128():155341. PubMed ID: 38518636
[TBL] [Abstract][Full Text] [Related]
2. The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis.
Pi S; Mao L; Chen J; Shi H; Liu Y; Guo X; Li Y; Zhou L; He H; Yu C; Liu J; Dang Y; Xia Y; He Q; Jin H; Li Y; Hu Y; Miao Y; Yue Z; Hu B
Autophagy; 2021 Apr; 17(4):980-1000. PubMed ID: 32160082
[TBL] [Abstract][Full Text] [Related]
3. Gualou-Xiebai herb pair ameliorate atherosclerosis in HFD-induced ApoE
Zhu L; Bao Y; Liu Z; Liu J; Li Z; Sun X; Zhou A; Wu H
J Ethnopharmacol; 2024 May; 326():117892. PubMed ID: 38350505
[TBL] [Abstract][Full Text] [Related]
4. Geniposide ameliorates atherosclerosis by restoring lipophagy via suppressing PARP1/PI3K/AKT signaling pathway.
Lin J; Wang X; Gu M; Chen Y; Xu J; Chau NV; Li J; Ji X; Chu Q; Qing L; Wu W
Phytomedicine; 2024 Jul; 129():155617. PubMed ID: 38614041
[TBL] [Abstract][Full Text] [Related]
5. A UHPLC-Q-TOF-MS-based serum and urine metabolomics approach reveals the mechanism of Gualou-Xiebai herb pair intervention against atherosclerosis process in ApoE
Wang Y; Sun X; Qiu J; Zhou A; Xu P; Liu Y; Wu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1215():123567. PubMed ID: 36529071
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the combination mechanisms of Gualou-Xiebai herb pair against atherosclerosis by network pharmacology and HPLC-Q-TOF-MS technology.
Liu Y; Zhong H; Xu P; Zhou A; Ding L; Qiu J; Wu H; Dai M
Front Pharmacol; 2022; 13():941400. PubMed ID: 36120369
[No Abstract] [Full Text] [Related]
7. Huanglian Jiedu decoction inhibits vascular smooth muscle cell-derived foam cell formation by activating autophagy via suppressing P2RY12.
Lin J; Gu M; Wang X; Chen Y; Chau NV; Li J; Chu Q; Qing L; Wu W
J Ethnopharmacol; 2024 Jun; 328():118125. PubMed ID: 38561055
[TBL] [Abstract][Full Text] [Related]
8. Bisdemethoxycurcumin suppresses the progression of atherosclerosis and VSMC-derived foam cell formation by promoting lipophagy.
Zuo J; Guo S; Qin X
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3659-3670. PubMed ID: 37289282
[TBL] [Abstract][Full Text] [Related]
9. Curcumin-mediated Photodynamic Therapy Inhibits the Phenotypic Transformation, Migration, and Foaming of Oxidized Low-density Lipoprotein-treated Vascular Smooth Muscle Cells by Promoting Autophagy.
Wang G; Zhu Y; Li K; Liao B; Wang F; Shao L; Huang L; Bai D
J Cardiovasc Pharmacol; 2021 Jun; 78(2):308-318. PubMed ID: 34091481
[TBL] [Abstract][Full Text] [Related]
10. SCD1 activation impedes foam cell formation by inducing lipophagy in oxLDL-treated human vascular smooth muscle cells.
Pi H; Wang Z; Liu M; Deng P; Yu Z; Zhou Z; Gao F
J Cell Mol Med; 2019 Aug; 23(8):5259-5269. PubMed ID: 31119852
[TBL] [Abstract][Full Text] [Related]
11. Celastrol suppresses lipid accumulation through LXRα/ABCA1 signaling pathway and autophagy in vascular smooth muscle cells.
Shi Y; Jiang S; Zhao T; Gong Y; Liao D; Qin L
Biochem Biophys Res Commun; 2020 Nov; 532(3):466-474. PubMed ID: 32892949
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle cell c-Fos is critical for foam cell formation and atherosclerosis.
Miao G; Zhao X; Chan SL; Zhang L; Li Y; Zhang Y; Zhang L; Wang B
Metabolism; 2022 Jul; 132():155213. PubMed ID: 35513168
[TBL] [Abstract][Full Text] [Related]
13. Extract of Gualou-Xiebai Herb Pair Improves Lipid Metabolism Disorders by Enhancing the Reverse Cholesterol Transport in Atherosclerosis Mice.
Liu Y; Wang T; Ding L; Li Z; Zhang Y; Dai M; Wu H
Curr Neurovasc Res; 2024 Apr; ():. PubMed ID: 38629368
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of the CTRP9 promoter region promotes Hcy induced VSMC lipid deposition and foam cell formation via negatively regulating ER stress.
Wang X; Ma X; Zeng Y; Xu L; Zhang M
Sci Rep; 2023 Nov; 13(1):19438. PubMed ID: 37945738
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan-induced PPARγ activity attenuates lipid accumulation in VSMCs via induction of autophagy.
Li BH; Liao SQ; Yin YW; Long CY; Guo L; Cao XJ; Liu Y; Zhou Y; Gao CY; Zhang LL; Li JC
Mol Biol Rep; 2015 Jan; 42(1):179-86. PubMed ID: 25249228
[TBL] [Abstract][Full Text] [Related]
16. FNDC5 inhibits foam cell formation and monocyte adhesion in vascular smooth muscle cells via suppressing NFκB-mediated NLRP3 upregulation.
Zang YH; Chen D; Zhou B; Chen AD; Wang JJ; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
Vascul Pharmacol; 2019 Oct; 121():106579. PubMed ID: 31319161
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Gualou Xiebai Banxia decoction on blood lipid content, oxidative stress and ox-LDL/Lox-1 pathway in ApoE-/- mice].
Guo JE; Mi SB; Yan XC; Xin SY; Gao F; Liang GH; Li JH
Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(4):752-757. PubMed ID: 28959848
[TBL] [Abstract][Full Text] [Related]
18. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
[No Abstract] [Full Text] [Related]
19. Amentoflavone prevents ox-LDL-induced lipid accumulation by suppressing the PPARγ/CD36 signal pathway.
Zhuang JL; Liu YY; Li ZZ; Zhuang QZ; Tang WZ; Xiong Y; Huang XZ
Toxicol Appl Pharmacol; 2021 Nov; 431():115733. PubMed ID: 34599948
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation.
Lin Y; Chen Y; Zhu N; Zhao S; Fan J; Liu E
Biomed Pharmacother; 2016 Oct; 83():466-476. PubMed ID: 27427853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
